Le Lézard
Classified in: Health, Science and technology, Business
Subjects: TNM, SVY, CXP

Windrose Consulting Group Acquires Parioforma as Part of Its Global Growth Strategy to Further Enhance Its Capabilities in Non-traditional Markets


LONDON, July 7, 2020 /PRNewswire/ -- Windrose Consulting Group, a global lifescience commercialization strategy consultancy, has acquired Parioforma, a leader in value, access and price assessments in non-traditional markets. The acquisition strengthens Windrose's expertise in emerging markets, which has been a significant driver of growth in recent years. Read more at www.windrosecg.com

Over the past 20 years, London-based Parioforma has developed a network and conducted research across much of Eastern Europe, Latin America, the Middle East, Asia and Africa. The deal will see Parioforma's Founding Director, Amy Morgan, assume the role of Head of Emerging Markets for Windrose Consulting Group. She said: "Windrose is well known for the quality of strategic support. We believe Parioforma can add to this with our substantial experience in emerging markets and are excited to join the team."

Matthew Storer, Managing Partner at Windrose Consulting Group, said: "Parioforma has been a valued partner for over a decade. They have developed an incredible understanding of healthcare systems and unparalleled network of decision makers. A third of our engagements now cover emerging markets and Parioforma is the perfect addition to further expand our capabilities in a fast growing part of the business."

About Parioforma

Parioforma is a business consultancy focusing on non-traditional markets that delivers high quality analysis and insights to support effective decision making to clients of all sizes in the chemical, technology, life science, healthcare, pharmaceutical and CRO sectors.

www.parioforma.com 

About Windrose Consulting Group

Windrose Consulting Group is a leading global strategy consulting firm helping life science companies maximize the commercial value of their products. Windrose specialize in product and portfolio planning, pricing and market access strategy, and value communication.

www.windrosecg.com

Contact:
Matthew Storer
[email protected]
+44 (0)208-057-8110

 

SOURCE Windrose Consulting Group


These press releases may also interest you

at 02:24
Today, 23 April 2024, the subscription period in SciBase Holding AB (publ) ('SciBase' or the 'Company') rights issue of units of up to approximately SEK 15 million commences (the 'Rights Issue'). The Rights Issue was resolved by the Board of...

at 02:05
Antech, the veterinary diagnostics company focused on partnering with veterinary professionals to predict, diagnose, and monitor wellness and disease, today announced the launch of the breakthrough in-hospital Nu.Q® Canine Cancer Test in Europe. A...

at 02:00
Red Arrow Therapeutics Inc. closed a $4.5M Seed Extension round, raising from four, top-tier institutional investors in Japan. Participants of this round are: Beyond Next Ventures Inc.The University of Tokyo Edge Capital Partners Co., Ltd.Keio...

at 01:05
Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care...

at 01:01
Allied Market Research published a report, titled, "Electroceuticals/Bioelectric Medicine Market by Product (Cardiac Pacemakers and Implantable Cardioverter Defibrillators, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus...

at 00:49
Allied Market Research published a report, titled, "Inhaled Nitric Oxide Market by Application (Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease, Acute Respiratory Distress Syndrome, and Others): Global Opportunity Analysis and...



News published on and distributed by: